CRTHF (CARsgen Therapeutics Holdings) Buyback Yield %: 0.98 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRTHF CARsgen Therapeutics Holdings Ltd CRTHF
21 GF Score
Price $1.91
! 3 Warning Signs
View Full Analysis

What is CARsgen Therapeutics Holdings Buyback Yield %?

CARsgen Therapeutics Holdings CRTHF 21 Buyback Yield % is 0.98 as of Jul. 16, 2026. GuruFocus rates CRTHF with a GF Score™ of 21/100. The stock has 3 warning signs investors should review. Among 740 Biotechnology companies, CARsgen Therapeutics Holdings ranks better than 93.38% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

CARsgen Therapeutics Holdings's current buyback yield was 0.98%.

CARsgen Therapeutics Holdings Buyback Yield % Related Terms

CARsgen Therapeutics Holdings Buyback Yield % Historical Data

* Premium members only.

The historical data trend for CARsgen Therapeutics Holdings's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CARsgen Therapeutics Holdings Buyback Yield % Chart

CARsgen Therapeutics Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial 0.00 -0.15 -0.10 1.60 1.29

CARsgen Therapeutics Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 3.66 1.03 -0.26 1.19

CRTHF vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, CARsgen Therapeutics Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CARsgen Therapeutics Holdings Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CARsgen Therapeutics Holdings's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where CARsgen Therapeutics Holdings's Buyback Yield % falls into.


CRTHF
21GF Score
CARsgen Therapeutics Holdings Ltd CRTHF
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CARsgen Therapeutics Holdings Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

CARsgen Therapeutics Holdings's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-16.367 + 4.124) / 952.7180152
=1.29%

CARsgen Therapeutics Holdings's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-16.367 + 4.124) / 952.7180152
=1.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.98 mean?
CARsgen Therapeutics Holdings (CRTHF) has a Buyback Yield % of 0.98 as of Jul. 16, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CARsgen Therapeutics Holdings and its competitors. According to the industry distribution chart, CARsgen Therapeutics Holdings ranks #49 out of 740 companies in the Biotechnology industry, placing it in the top 6.6%.
Is CARsgen Therapeutics Holdings' Buyback Yield % too high?
CARsgen Therapeutics Holdings' current Buyback Yield % is 0.98. Based on the distribution chart, CARsgen Therapeutics Holdings ranks #49 out of 740 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, CARsgen Therapeutics Holdings has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does CARsgen Therapeutics Holdings' Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CARsgen Therapeutics Holdings ranks #49 out of 740 companies for Buyback Yield %. This places CARsgen Therapeutics Holdings in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CARsgen Therapeutics Holdings and its competitors. CARsgen Therapeutics Holdings's current Buyback Yield % is 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARsgen Therapeutics Holdings stock overvalued right now?
CARsgen Therapeutics Holdings (CRTHF) has a current Buyback Yield % of 0.98. The current Buyback Yield % is 0.98. CARsgen Therapeutics Holdings' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For CARsgen Therapeutics Holdings (CRTHF), the current Buyback Yield % is 0.98 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CARsgen Therapeutics Holdings Business Description

Other Exchanges 02171:Hong Kong
Address No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America. During the year, a majority of the Group's revenue was derived from one customer located in the Chinese mainland.
21GF Score

Get the complete analysis for CRTHF

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.91
Price